Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults — United States, 2025
Link
Description
Reports on glucagon-like peptide-1 (GLP-1) use among adults, including use of compounded versions for chronic weight management. Also covers modified use due to cost- and access-related challenges. Includes data on GLP-1 use by metropolitan and nonmetropolitan location.
Author(s)
Samantha L. Pierce, Lilanthi Balasuriya, Lyudmyla Kompaniyets, Alyson B. Goodman
Citation
MMWR (Morbidity and Mortality Weekly Report), 75(44), 645-651
Date
11/2026
Organization
Centers for Disease Control and Prevention
Tagged as
Access
· Diabetes
· Obesity and weight control
· Pharmacy and prescription drugs
· Rural-urban differences
· Statistics and data